Abstract
Epigenetic mechanisms, like DNA methylation, determine immune cell phenotype. To understand the epigenetic alterations induced by helminth co-infections, we evaluated the longitudinal effect of ascariasis and schistosomiasis infection on CD4+ T cell DNA methylation and the downstream tuberculosis (TB)-specific and BCG-induced immune phenotype. All experiments were performed on human primary immune cells from a longitudinal cohort of recently TB-exposed children. Compared to age-matched uninfected controls, children with active Schistosoma haematobium and Ascaris lumbricoides infection had 751 differentially DNA methylated genes with 72% hyper-methylated. Gene ontology pathway analysis identified inhibition of IFN-γ signaling, cellular proliferation, and the Th1 pathway. Targeted RT-PCR after methyl-specific endonuclease digestion confirmed DNA hyper-methylation of the transcription factors BATF3, ID2, STAT5A, IRF5, PPARg, RUNX2, IRF4 and NFATC1 and cytokines or cytokine receptors IFNGR1, TNFS11, RELT (TNF receptor), IL12RB2 and IL12B (p< 0.001; Sidak-Bonferroni). Functional blockage of the IFN-γ signaling pathway was confirmed with helminth-infected individuals having decreased up-regulation of IFN-γ-inducible genes (Mann-Whitney p < 0.05). Hypo-methylation of the IL-4 pathway and DNA hyper-methylation of the Th1 pathway was confirmed by antigen-specific multidimensional flow cytometry demonstrating decreased TB-specific IFN-γ and TNF and increased IL-4 production by CD4+ T cells (Wilcoxon signed rank P<0.05). In S. haematobium infected individuals, these DNA methylation and immune phenotypic changes persisted at least six months after successful deworming. This work demonstrates that helminth infection induces DNA methylation and immune perturbations that inhibit TB-specific immune control and that the duration of these changes are helminth-specific.
Keywords: Tuberculosis, Schistosomiasis, Helminth, CD4 T cells, DNA methylation, T cell function, multi-parametric flow cytometry
Introduction
The immune system has multiple mechanisms to remain responsive to changing environments. It is now clear that both the innate and adaptive immune response use epigenetic mechanisms of gene regulation to maintain long-term phenotypes. For example, monocytes “trained” with β-glucan or BCG undergo epigenetic chromatin alterations that alter TNF and IL-6 production and improve Staphylococcus, Candida and mycobacterial killing(1, 2). Long-term phenotypic changes in adaptive immunity are similarly epigenetically mediated. The RAG-mediated T cell receptor (TCR) rearrangement requires hypo-methylation of RAG and other critical genes(3). After TCR rearrangement, T cells remain responsive to changing environments via epigenetic modifications that polarize CD4+ T cells into phenotypic subsets (Th1, Th2, Th9, Th17, Tregs, Th22, and Tfh)(4-6). To differentiate into a Th1 CD4+ T cell, the IFNG promoter is de-methylated and the IL4 locus undergoes repressive histone modifications(7-9). While previously thought to be immutable, epigenetic mechanisms have recently been described that allow T cells to shift between Th1 and Th2 phenotypes depending on environmental stimuli(10). Understanding the duration and mechanisms of epigenetic mediated immune polarization is critical to predicting and reversing detrimental immune perturbations.
Helminths are a heterogeneous group of parasites estimated to affect a quarter of the world's population(11, 12). While most infections are subclinical, they can induce growth retardation, nutritional deficiencies and profoundly perturb immunogenicity(12-14). The helminth-induced immune response is characterized by tolerance and a Type 2 immune polarization(15, 16) with decreased IFN-γ, IL-12 and IL-17(17), and increased T regulatory cells (Tregs)(18), IL-4, IL-5, IL-10(19) and TGF-β(20). This profound Type 2 and immune-tolerant phenotype undermines the Type 1 immune response to cholera, salmonella, tetanus, and BCG(21-25) and is the suspected rational for increased TB disease progression among helminth infected individuals(11, 26-28). In contrast to the Type 2 immune response required to expel helminths, Mycobacterium tuberculosis (Mtb) infection requires a Type 1 polarized CD4-macrophage immune axis for effective host response
Individuals with IL-12- IFN-γ axis defects due to Mendelian Susceptibility to Mycobacterial Diseases (MSMD), HIV and TNF-inhibitors are prone to disseminated BCG, TB disease progression and infection with other intracellular pathogens(29, 30). Stimulation of macrophages with TNF and IFN-γ induces intracellular killing via phago-lysosome maturation and nitric oxide (NO) production, while IL-4 induces a diametrically opposed reaction to direct macrophages away from NO and towards collagen synthesis(31). Therefore, when macrophages are polarized with IL-4 they exhibit decreased phago-lysosome maturation, diminished NO production and reduced Mtb killing(32-35).
In the mêlée of host-pathogen interactions, pathogens induce epigenetic changes to subvert host immunity. HIV induces DNA methyltransferases (DNMT) expression that hyper-methylates IFNG and IL2. HIV also hypo-methylates PD1, resulting in decreased IFN- γ and IL-2 while increasing PD-1(36-39). Similar to other intracellular pathogens(40-42), Mtb induces epigenetic changes that benefit mycobacterial survival by altering macrophage (MΦ) antigen-presentation and inflammasome function(43-48). CD4+ T cell cytokine production is critical for macrophage polarization and Mtb control(49, 50). In murine studies, schistosomiasis induces epigenetic changes that induce alternative activated macrophages(7) and a Th2 CD4+ T cell phenotype characterized by DNA hyper-methylation of the IFNG promoter(8). Therefore, to elucidate the longitudinal epigenetic-immune effects of helminth co-infection, we evaluated the effect of Schistosoma haematobium and Ascaris lumbricoides on CD4+ T cell DNA methylation and TB-specific immune phenotype. These studies indicate that Schistosoma and Ascaris induce global changes in host DNA methylation and immune phenotypic changes in CD4+ T cells. For S. haematobium, these host DNA methylation and immune phenotypic perturbations are relatively stable and persist at least six months after successful anti-helminthic therapy.
Patients and Methods
Cohort
Asymptomatic children 6 months to 15 years of age with recent intense TB exposure (as quantified by a standardized TB exposure score(51)) were enrolled after obtaining assent and written informed consent of their parent or caregiver. As per national guidelines, participants were empirically dewormed with albendazole and treated with isoniazid preventative therapy (IPT) if <5 years of age or HIV-infected. Individuals with HIV infection were excluded from this analysis. All individuals were BCG-vaccinated as confirmed by BCG scar and/ or vaccine card. Participants completed clinical evaluation at 2 and 6 months for TB symptoms and provided stool and urine for helminth evaluation. Blood was collected for helminth serology and peripheral blood mononuclear cell (PBMC) collection at each visit. Stool and urine were collected for parasite microscopy and PCR at each visit. The protocol was reviewed and approved by the Baylor College of Medicine Children's Foundation-Swaziland (BCMCF-SD), Baylor College of Medicine and the Swaziland Scientific and Ethics Committee. The protocol was also reviewed at the Centers for Disease Control and Prevention, which issued a non-engaged determination. All methods were performed in compliance with institutional and international guidelines for the Protection of Human Subjects in concordance with the Declaration of Helsinki.
Helminth Status
To comprehensively describe a child's helminth status, serology, ova and parasite microscopy (O&P) and helminth-specific multi-parallel quantitative real-time PCR were performed. Schistosomiasis serology was performed by standard ELISA. In brief, 96-well ELISA plates were coated with 2μg/ml Schistosoma mansoni soluble egg antigen (SEA) in 0.1M sodium bicarbonate buffer (pH 9.6) for 2 hours followed by washing with PBS + 0.3% Tween 20, blocking with PBS/Tween containing 5% dry milk powder. Plates were again washed and incubated with 1:50 dilution of participant plasma in PBS/Tween/milk for 30 minutes. Plates were again washed and incubated with a 1:50,000 dilution of horseradish peroxidase conjugated mouse anti-human IgG (Southern Biotech, Birminham, AL) for 30 minutes. After a final wash, SureBlue™ TMB (Kirkegaard & Perry, Gaithersbug, MD) substrate was added to plates for 5 minutes and the reaction was stopped using 1N H2SO4. Plates were read at 450nm on a Molecular Devices (Sunnyvale, CA) microplate reader and patient results were compared to a standard curve consisting of sera from confirmed schistosomiasis patients that was included on each plate using SOFTmaxPro software (Molecular Devices).
Stool microscopy was performed using the McMaster protocol(52). Two grams of stool were added to 28mL of NaCl and sugar flotation solution and homogenized by aggressive hand mixing followed by straining and viewing on a McMaster chamber slide. Urine microscopy was performed after 400g centrifugation.
Multi-parallel helminth qPCR was performed as previously described(53). DNA was extracted from 50mg of stool using the MP FastDNA for Soil Kit. For urine DNA extraction, the concentrated pellet was heated at 90°C for 10 minutes followed by DNA isolation using the MP FastDNA kit. From stool, helminth-specific PCR was performed for A. lumbricoides, Necator americanus, Ancylostoma duodenale, Trichuris trichiura and Strongyloides stercoralis using primers and FAM-labeled minor groove binding probes (Supplemental table I). Similarly, qPCR specific for S. haematobium was performed from the DNA isolated from urine with organism specific primers and probes (Supplemental Table I). The qPCR reactions were performed in duplicate with 2 μL of stool or urine derived template DNA, 900 nM primers, 250 nM probe and 3.5 μL of TaqMan Fast MasterMix and acquired on a QuantStudio3 in Mbabane, Swaziland after 40 cycles. Quantification was performed using a standard curve consisting of 10-fold serial dilutions of purified plasmid DNA containing the target sequences.
Composite helminth status was defined according to serology, microscopy and PCR status. Active helminth infection was defined as microscopy and/ or PCR positive. Remote infection was classified as serology positive, but microscopy and PCR negative both at baseline and two and six-month follow-up. Uninfected controls were microscopy, PCR and serology negative.
DNA Methylation
To evaluate CD4+ T cell DNA methylation, CD14 positive selection was followed by CD4 negative selection (StemCell) to obtain >93% CD4+ T cell population determined by flow cytometry. Cellular DNA was then isolated using the DNeasy Lymphocyte protocol (Qiagen). To perform the DNA MethylEPIC array, Genomic DNA (gDNA) from CD4+ T cells was quantified using a Qubit 3.0 fluorometer (Thermofisher Scientific, MA, USA). gDNA quality was analyzed using Agilent 4200 Tape Station System (Agilent Technologies, Inc. CA, USA) for integrity check and Nanodrop ND1000 spectrophotometer for purity check. gDNA (250–750 ng) was treated with sodium bisulphite using the Zymo EZ DNA Methylation Kit (Zymo Research Corp., CA, USA)). We followed the Illumina recommended incubation conditions during bisulfite conversion to maximize DNA conversion rate. Illumina Infinium HumanMethylation850 (HM850) and HumanMethylationEPIC (EPIC) BeadChip (Illumina, CA, USA) were run on an Illumina iScan System (Illumina, CA, USA) using the manufacturer's standard protocol.
Validation of the Infinium DNA Methylation EPIC data was performed using real-time PCR after isolated DNA underwent methylation-sensitive or dependent digestion with a DNA MethylationEpitect II kit. The relative percentage of methylated and unmethylated DNA was determined relative to mock and double digested DNA as previously described(54).
Multi-dimensional Immune Profiling
To identify TB-specific and BCG induced immunity, PBMCs were stimulated with 2.5 μg each of ESAT-6 and CFP-10 overlapping peptide pools or 5μg of BCG sonicate, respectively. BCG and TB-specific immune responses were compared to vehicular control (dimethyl sulfoxide) stimulation and staphylococcal enterotoxin B was used as a positive control. Cell stimulations occurred in the presence of brefeldin A (1μg/mL), monensin (0.7 μg/mL) and CD28/CD49 (2.5 μg/mL). Following overnight (16 hour) stimulation, cells were stained with an amine reactive viability dye (Ghost dye), surface antibodies (CD4, CD8, CD56 and PD-1) and intracellular antibodies (CD3, IFN-γ, TNF, IL-4, IL-10, IL-13, perforin, T-bet, GATA-3, and Ki-67) and acquired on a BD LSR II Fortessa (Supplemental Table I). A minimum of 70% viability was the threshold for credible data. All reported TB-specific or BCG-induced values were subtracted from the background non-stimulated immune response.
Gene Expression
PBMCs were stimulated overnight with IFN-γ (50ng/mL) or media control and 16 hours later CD4+ T cells were isolated via magnetic bead negative selection as described above. From 100ng of RNA, the Human Immunology v2 probe set was performed using the NanoString nCounter. Background noise was normalized using 8 negative control probes and the geometric mean of positive controls and 15 housekeeping genes.
Monocyte-Derived Macrophage (MDMΦ) Immune Polarization
Adherent monocytes from healthy control PBMCs were cultured for 7 days at 37°C with 10% human AB serum and 10ng/mL M-CSF and GM-CSF. After 7-day conversion to MDMΦ, the cells were polarized with IL-4 20ng/mL or IFN-γ 50 ng/mL for 48 hours and then brought to the BSL-3. The MDMΦs from three healthy controls were incubated with live H37Rv Mtb at an MOI of 3:1 overnight, non-phagocytosed extra-cellular bacilli were removed by washing, MDMΦ were lysed with ice cold deonized water, and mycobacteria were cultured on 7H11 plates at 1:5 and 1:25 dilutions. Twenty-one days later, colony-forming units (CFU) were manually counted.
Statistical Analysis
Flow Cytometry data analysis was performed in FlowJo (TreeStar, Ashland, OR); GraphPad 6.0 (GraphPad Software), and SPICE (available at http://exon.niaid.nih.gov/spice). The non-parametric Mann-Whitney test was used to compare data sets. For multiple comparisons, the Sidak-Bonferroni test was performed. Statistically significant differentially methylated genes were visualized using Ingenuity Pathway Analysis (Qiagen Bioinformatics). IDAT files from methylation data were imported into R statistical system using the Bioconductor (http://www.bioconductor.org) minfi package(55). Preprocessed and normalized data from minfi was used by Bioconductor limma package to identify the significantly differentiated probes with p-value <0.05 and log2 fold change > 2 or <0.5(55). Statistically significant differentially methylated genes were visualized using Ingenuity Pathway Analysis (Qiagen Bioinformatics). Further gene enrichment analysis was performed by employing the gene set collections compiled by the Molecular Signature Database (MSigDB, http://www.broadinstitute.org/gsea/msigdb/) using the hypergeometric distribution (statistical significance achieved at P < 0.05)(56).
Results
Participant demographics
Among the children enrolled who had exposure to microbiologically confirmed pulmonary TB case in the past 6 months, fifty-nine percent of children were female and the median age was 6.1 (IQR 2.7-10.5). The median and mean TB exposure score was 7 (Table I).
Table 1. Demographics and TB exposure of clinical cohort.
n | Microscopy or PCR | Serology | TB Exposure Score | SEX | Age | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
MEAN | MEDIAN | P-value | (% Male) | MEDIAN | P-value | IQ1 | IQ3 | ||||
Helminth Uninfected | 18 | Negative | Negative | 7.25 | 8 | … | 42.00% | 4.5 | … | 2.4 | 8.8 |
Active Helminth infection | 8 | Positive | Pos/Neg | 7 | 6 | 0.7 | 33.30% | 4.9 | 0.9 | 2.1 | 9.3 |
Past Schistosomiasis | 6 | Negative | SEA positive | 6.8 | 7 | 0.6 | 33.30% | 8.5 | 0.4 | 2.8 | 9 |
Past Ascaris | 6 | Negative | Ascaris Positive | 6.6 | 6 | 0.3 | 40.00% | 7.5 | 0.2 | 6.6 | 10.5 |
Helminth Infection induces CD4 DNA Methylation Changes that Persist after Schistosomiasis
We evaluated how helminth status altered CD4+ T cell DNA methylation. Individuals with current ascaris or schistosome infection (n = 8), confirmed by ova and parasite (O&P) microscopy or by multi-parallel PCR, have unique CD4+ T cell DNA methylation signatures compared to uninfected, TB-exposed children (n = 18). Using the DNA Methylation EPIC array to analyze ∼850,000 CpG probes, helminth-infected individuals had 751 genes with differentially methylated probes (DMPs) compared to uninfected controls (FDR <1%) and of which 72% were hyper-methylated. Gene ontology (GO) analysis identified significant DNA methylation perturbation in the immune system in the IL-4, IFN-γ response, regulation of cytokine production, cell proliferation, mTOR signaling and glycolysis (Figure 1).
To validate these results, targeted DNA methylation of specific genes was evaluated by PCR after methyl-specific endonuclease digestion. Compared to helminth uninfected healthy controls, helminth infected individuals had increased DNA methylation for the transcription factors IRF4 (5.7%; IQR 4.7-7.0% vs. 0.6%; IQR 0 - 1.1%), IRF5 (34.8%; IQR 27.5 – 38.4% vs. 0.9%; IQR 0 – 1.4%), BATF3 50%; IQR 50-50% vs. 2.2%; IQR 1.6-2.7%), ID2 48.4%; IQR 50-50% vs. 1.9%; IQR -0.2-1.3%), RUNX2 (33.3%; IQR 26.2 - 37.4% vs 1.2% IQR 0 – 1.2%), PPARg (46.3%; IQR 46.2 – 50.0% vs. 2.3%; IQR 1.5% - 3.0%) and NFATC1 60.9%; IQR 60.4 – 71.4% vs. 3.0%; IQR 0 – 4.4%) (p< 0.001; Sidak-Bonferroni; Figure 2a; Table 2). Similarly, compared to un-infected controls, helminth infected children had increased CD4+ DNA methylation of cytokine or cytokine receptors IFNGR1 20.1%; IQR 18.4 – 20.2% vs. 0.6%; 0 – 0.6%), TNFS11 5.8%; IQR 4.9 – 7.7% vs. 0.6%; IQR 0.3 – 0.7%), RELT (TNF receptor) 12.1%; IQR 7.6 – 16.2% vs. 0.9% IQR 0.5 – 1.5%), IL12RB2 34.1%; IQR 28.7 – 34.9% vs. 2.2%; IQR 0 – 3.4%) and IL12B (14.3%; IQR 8.4 – 15.6% vs. 0.7%; IQR 0 – 1.0%) (p< 0.001; Sidak-Bonferroni; Figure 2a; Table 2). By contrast, MAP1LC3, a gene essential in autophagy, was hypo-methylated 9% in active helminth infection and remained hypo-methylated in remote schistosomiasis (negative by stool and urine O&P and PCR for helminth infection, but serology positive) infection (p< 0.001; Sidak-Bonferroni; Figure 2a)
Table 2. Median and interquartile range of DNA methylation differences in helminth-infected and un-infected individuals.
Helminth | Uninfected controls | |||
---|---|---|---|---|
Median | IQ1-IQ3 | Median | IQ1-IQ3 | |
IRF4 | 5.70% | 4.7-7.0% | 0.60% | 0 - 1.1% |
IRF5 | 34.50% | 27.5 - 38.4% | 0.90% | 0 - 1.4% |
BATF3 | 50% | 50 - 50% | 2.20% | 1.6 - 2.7% |
ID2 | 48.40% | 50 - 50% | 1.90% | 0.2 - 1.3% |
RUNX2 | 33.30% | 26.2 - 37.4% | 1.20% | 0 - 1.2% |
PPARg | 46.30% | 46.2 - 50% | 2.30% | 1.5 - 3.0% |
NFATC1 | 60.90% | 60.4 - 71.4% | 3.00% | 0 - 4.4% |
IFNGR1 | 20.10% | 18.4 - 20.2% | 0.60% | 0 - 0.6% |
TNFS11 | 5.80% | 4.9 - 7.7% | 0.60% | 0.3 - 0.7% |
RELT | 12.10% | 7.6 - 16.2% | 0.90% | 0.5 - 1.5% |
IL12RB2 | 34.40% | 28.7 - 34.9% | 0.20% | 0 - 3.4% |
IL12B | 14.30% | 8.4 - 15.6% | 0.70% | 0 - 1.0% |
Children with remote Ascaris infection had a CD4+ DNA methylation signature statistically similar to the healthy control group (Figure 2a). By contrast, children with remote schistosomiasis had CD4+ DNA methylation signature statistically similar to the active helminth infection group (Figure 2a). To further evaluate if schistosomiasis induces persistent DNA methylation alterations in CD4+ T cells, we repeated the DNA methylation evaluation 6 months after enrollment with negative microscopy and PCR at two and six months to confirm successful deworming. Six months after successful deworming, the DNA methylation of CD4+ T cells remained elevated and statistically similar to actively infected individuals (Figure 2a). Comparison between DNA methylation and respective helminth status is shown in the heatmap, Figure 2b. Pathway analysis of these results identified helminth-induced inhibition of the Th1 and IFN-γ signaling pathway (Figure 3 p = 2.97e-33 and p = 6.01e-17, respectively).
Helminth Infection Mutes Up-Regulation of IFN-γ-Inducible Gene Expression
To validate effect of helminth-induced DNA hyper-methylation of the IFN-γ signaling pathway, CD4+ T cells were stimulated overnight with 50ng/mL of IFN-γ. The IFN-γ inducible genes specific to CD4+ T cells(57) IDO, SERPING1, STAT1, IRF1, FCGR1A/B, GBP1, ICAM1, HLA-DRA, HLA-DRB3 and HLA-DQA1 were evaluated demonstrating that IDO up-regulation was muted by helminth infection (IDO fold up-regulation 12.24; IQR 9.4 – 16.0 vs. 0.02; IQR -0.3 – 0.4; p = 0.001 Sidak-Bonferroni; Figure 4a). Using a previously described CD4+ T cell IFN-γ inducible genes signature(57), helminths induced a 6.7-fold decrease in IFN-γ-stimulated gene up-regulation (25.5, IQR 16.6 – 38.7 vs. 3.8, IQR 0.8 – 6.7; P<0.05 by Mann-Whitney test; Figure 4b).
Helminth Infection Results in Persistent Immune Phenotypic Perturbations
DNA methylation decreases transcription factor binding affinity, thereby repressing gene expression. To validate the functional impact of helminth infection-induced DNA methylation changes in CD4+ T cell, we performed flow cytometry based multi-dimensional immune profiling after ex vivo stimulation with TB-specific peptides or BCG sonicate. The characteristic immune alteration induced by helminth infections is an increase in IL-4 production by CD4+ T cells, as well as, by other lymphocyte, mast cells, eosinophils and basophils(58, 59). We found that PBMCs from recently-TB-exposed individuals with active helminth infection had an increased frequency of TB-specific (ESAT-6 and CFP-10 stimulation) CD4+ T cells up-regulating IL-4 (median 3.0%; IQR 3.0 – 4.5% vs.0.3%; IQR 0.07 – 0.37); Wilcoxon signed rank P<0.05; Figure 5). The increased frequency of IL-4-producing subsets was associated with a decrease in TB-specific CD4+ T cells producing IFN-γ and TNF (median 0.0%; IQR 0.0 – 0.0 vs.0.4%; IQR 0.16 –0.5%); Wilcoxon signed rank p< 0.05). DNA methylation alterations in individuals with active helminth infection were associated with a decrease in TB-specific proliferation. Similarly, TB-specific up-regulation of Ki-67 was decreased in helminth-infected individuals compared to uninfected controls (median 0.1% (IQR 0.03 – 0.18%) vs. 0.08% (IQR 0.05 – 0.1%); Wilcoxon signed rank P <0.05). Furthermore, helminth infected individuals had a decrease in the quantity of TB-specific proliferating CD4+ T cells (increase in Ki-67 above baseline) producing TNF and IFN-γ (median 0.0 (IQR 0.00 – 0.00) vs. 0.02% (IQR 0.01 –0.05%; Wilcoxon signed rank P <0.05; Supplemental Figure 1). Since all individuals were BCG vaccinated, the BCG-induced immune response was also evaluated. Notably, individuals with active helminth-infection demonstrated an increased percentage of BCG-induced CD4+ T cells up-regulating IL-4 (median 1.2% (IQR 0.8 – 1.8%) vs. 0.7 (IQR 0.3 –0.8%); Wilcoxon signed rank p<0.05; Supplemental Figure 2).
We next evaluated the persistence of helminth-induced immune perturbations on TB-specific and BCG-induced immune responses 6 months after anti-helminth therapy. Successful anti-helminth therapy was documented with negative repeat stool and urine O&P and helminth PCR at 2 and 6 months after study enrollment. For schistosomiasis, but not ascariasis, six months after successful anti-helminthic therapy, the CD4+ T cell immune phenotype demonstrated an increase percent of IL-4 and decreased percentage of TNF and IFN-γ antigen-specific producing CD4+ T cells compared to uninfected controls (median 0.05% (IQR 0.01 – 0.05%) vs.0.4% (IQR 0.16 –0.5%); Wilcoxon signed rank p<0.05; Figure 6). Previous reports have established that the supernatant of CD4+ T cells incubated with SEA were less effective at forming a mature phago-lysosome with intracellular Mtb(32). Consistent with this, monocyte-derived macrophages treated with IL-4 instead of IFN-γ, had a 3.8-fold decreased ability to kill intracellular Mtb (Wilcoxon signed rank p = 0.039; Supplemental Figure 3).
Discussion
To remain responsive to changing environments, the immune system undergoes epigenetic modifications to refine cell phenotypes(10, 60). CD4+ T cells in particular have an epigenetically mediated spectrum of phenotypes that respond to intracellular pathogens (Th1), extracellular parasites (Th2 and Th9), bacteria (Th17 and Th22), and limit autoimmunity (Treg) (60). After encountering a pathogen, both the innate and adaptive immune response retain immunologic memory(2). Here we show that recently TB-exposed, asymptomatic children with helminth infection have CD4+ T cell DNA methylation signatures that inhibit the TB-specific and BCG-induced Th1 immune phenotype. Of interest, these CD4+ T cell DNA methylation and immune phenotype perturbations persist for at least 6 months in children previously infected with S. haematobium, but not in children previously infected with A. lumbricoides.
Helminth infection induces a Th2 and immune-tolerant response that subverts cell-mediated immunity to HBV, BCG and cholera(21, 58, 61). The duration of helminth-induced immune changes has been previously evaluated with mixed results. After leaving helminth-endemic areas, refugees experienced decreased eosinophilia, IgE and HLA-DR on CD3+ T cells 6-12 months after deworming(61). However other studies have shown that remote Ascariasis (as determined by elevated ascaris-specific IgE) is inversely associated with tuberculin skin test (TST) reactivity(62). Further, fourteen months after in utero schistosomiasis exposure, children still had a 25-fold decrease in PPD-induced IFN-γ production(21). The mixed results from previous studies are likely due to variability of helminths evaluated and variability of the immune assessments performed. The cohort in the present study consisted of Ascaris and S. haematobium-infected children who were recently household contacts of individuals with microbiologically confirmed TB. Their helminth status was documented by urine and stool PCR, microscopy and serology. Participants were dewormed and reevaluated 2 and 6 months later to confirm conversion from active to remote helminth status. This is the first human report to show that schistosomiasis has persistent DNA methylation and TB-specific and BCG-induced immune perturbations that remain shifted away from Th1 immunity six months after successful S. haematobium deworming.
There is a paucity of data describing the duration of epigenetic control of immune responses after a host-pathogen interaction. In vitro, memory Th1 and Th2 cells retain post-translational epigenetic modifications (H3K4Ac of IL4 and IFNG promoter) for greater than 20 cell divisions(63). In a sepsis model, IL-12 remained epigenetically inhibited for at least 6 weeks(64). In vivo, epigenetic alterations persisted 3 months after BCG vaccination(2) and CD8+ lymphocytes retain permissive PD1 DNA hypomethylation marks two years after successful antiretroviral therapy(38). Here we show that the schistosomiasis-induced CD4+ T cells DNA methylation signature persist at least 6 months after successful deworming for schistosomiasis, but not ascariasis. The continued effect of schistosome infections on the host immune system after treatment is consistent with observations that the pathology associated with schistosomiasis endures beyond infection(65, 66). The difference in the duration of DNA methylation and immune perturbations are likely related to the different life cycles of these organisms. While Ascaris is an intraluminal infection and are passed out of the body in tact following treatment, S. haematobium worms live in the venous plexus and successful chemotherapy eliminate the worms, however the eggs remain imbedded in the tissue causing inflammation that can persist for years after successful treatment(66). For at least some period of time, the eggs continue to induce a Type 2 immune response that is diametrically opposed to the Type 1 immune response directed at intracellular co-infections such as Mtb(11, 12, 26, 27, 61). Deworming combined with BCG revaccination was successful at restoring Ag-specific cell-mediated immunity in a previous study of ascaris and hookworm infected individuals(22). This simple strategy should be evaluated in a schistosomiasis-infected population.
After schistosome infection, STAT-6 and JMJD3 mediated alterations in histone H3 lysine-27 (H3K27) tri-methylation induce an alternatively-activated macrophage phenotype(7, 67). Similarly, murine studies have shown that schistosomiasis induces CD4+ T cells to shift to a Th2 phenotype associated with DNA hypomethylation of the IL4 and Gata3 genes(68). While IL4 and Gata3 were not hypo-methylated in this cohort, the gene ontology pathway regulating IL-4 was hypomethylated (Figure 1) with associated increased production of IL-4 (Figure 4). This supports the previous evidence that the Th2 pathway is epigenetically selected and not a default pathway(69).
There are numerous potential non-exclusive mechanisms through which helminth may alter DNA methylation. Recent studies have documented that pathogens secrete products, such as methyltransferases, that directly alter the host epigenome (44, 46, 48, 70). Several helminth secreted products target host immunity and future studies should evaluate the ability of these excretory products to directly, or indirectly, alter the host epigenome. In addition, many of the helminth-secreted products alter host metabolites(71). Increasingly, oncology and immunology studies have delineated metabolites that alter host epigenetics changes and drive cancer(72) and vaccine immunogenicity(72-74). Helminth metabolic-epigenetic-immune studies are likely to identify helminth metabolic alterations that drive epigenetic-mediated immune changes. Chronic inflammation is another potential mechanism through which helminth induced epigenetic changes occur. Murine LCMV and cancer models show that chronic infection results in persistent epigenetic-mediated immune exhaustion(75, 76). A similar pathway likely occurs in chronic helminth-induced inflammation that may alter the host immune response to Mtb.
The importance of the type 1 immune response in controlling mycobacterial infections is highlighted by the rare inherited primary immune deficiencies known as Mendelian Susceptibility to Mycobacterial Disease (MSMDs). MSMDs can be categorized as genetic defects upstream of IFN-γ production (defects in IL12B, IL12RB, NEMO, ISG15, NEMO) or defects that block the IFN-γ signaling pathway (IFNGR1, IFNGR2, STAT1, IRF8)(30). This work shows that helminths perturb mycobacterial immune response by increasing DNA methylation of both the upstream induction of IFN-γ (IL12B, IL12RB) and the downstream IFN-γ signaling pathway (IFNGR1, IFNGR2, JAK1, STAT1). DNA hyper-methylation of IL12B and IL12RB (Figure 2) in combination with DNA hypermethylation of Th1 critical transcription factors (Figure 3) are a likely major factor leading to the decreased TB-specific IFN-γ production (Figure 5-6). Further, by increasing the DNA methylation of the downstream IFN-γ signaling pathway, IFN-γ was less capable of up-regulating the IFN-γ-inducible genes (Figure 4). These experiments focused on the DNA methylation and immune phenotype of CD4+ T cells. A critical role of IFN-γ is to induce phenotypic changes in macrophages, specifically to up-regulate genes necessary for phagolysosome maturation, generation of lysosomal acidification and ROS and NOS production(57). Future studies should evaluate if DNA methylation changes in the IFN-γ signaling pathway block macrophage phagolysosome maturation, ROS and NOS, generation of lysosomal acidification with resultant decreased intracellular Mtb killing.
Helminths perturb the immune system and increase the risk of TB progression. Therefore, they are an excellent model to elucidate the immunity necessary to control M. tuberculosis infection. In this study, we confirm that ex vivo IFN-γ improves Mtb killing, but that helminths induce epigenetic DNA methylation changes in CD4+ T cells that hamper both IFN-γ production and the downstream intracellular IFN-γ signaling pathway. These findings highlight the importance of persistent DNA methylation perturbations in immune function and provide plausible explanations for increased rate of TB progression in the setting of helminth co-infection. Future studies should evaluate means to reverse helminth-induced detrimental DNA methylation changes to restore mycobacterial immunity. Similarly, longitudinal cohort studies need to be undertaken to evaluate if DNA methylation signatures described here correlate with increased rates of TB progression.
Supplementary Material
Acknowledgments
Funding Source: This work was supported by Burroughs Wellcome Fund/ American Society of Tropical Medicine and Hygiene–Postdoctoral Fellowship in Tropical Infectious Diseases (early career grant), Thrasher Research Fund (early career grant), and the National Institutes of Health (grants T-32 AI 55413–11 [to ARD]
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.
References
- 1.van der Meer JW, Joosten LA, Riksen N, Netea MG. Trained immunity: A smart way to enhance innate immune defence. Mol Immunol. 2015;68:40–44. doi: 10.1016/j.molimm.2015.06.019. [DOI] [PubMed] [Google Scholar]
- 2.Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, Jacobs C, van Loenhout J, de Jong D, Stunnenberg HG, Xavier RJ, van der Meer JW, van Crevel R, Netea MG. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proceedings of the National Academy of Sciences of the United States of America. 2012;109:17537–17542. doi: 10.1073/pnas.1202870109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Rodriguez RM, Suarez-Alvarez B, Mosen-Ansorena D, Garcia-Peydro M, Fuentes P, Garcia-Leon MJ, Gonzalez-Lahera A, Macias-Camara N, Toribio ML, Aransay AM, Lopez-Larrea C. Regulation of the transcriptional program by DNA methylation during human alphabeta T-cell development. Nucleic Acids Res. 2015;43:760–774. doi: 10.1093/nar/gku1340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kanno Y, Vahedi G, Hirahara K, Singleton K, O'Shea JJ. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu Rev Immunol. 2012;30:707–731. doi: 10.1146/annurev-immunol-020711-075058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Allan RS, Zueva E, Cammas F, Schreiber HA, Masson V, Belz GT, Roche D, Maison C, Quivy JP, Almouzni G, Amigorena S. An epigenetic silencing pathway controlling T helper 2 cell lineage commitment. Nature. 2012;487:249–253. doi: 10.1038/nature11173. [DOI] [PubMed] [Google Scholar]
- 6.Falvo JV, Jasenosky LD, Kruidenier L, Goldfeld AE. Epigenetic control of cytokine gene expression: regulation of the TNF/LT locus and T helper cell differentiation. Adv Immunol. 2013;118:37–128. doi: 10.1016/B978-0-12-407708-9.00002-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ishii M, Wen H, Corsa CA, Liu T, Coelho AL, Allen RM, Carson WFt, Cavassani KA, Li X, Lukacs NW, Hogaboam CM, Dou Y, Kunkel SL. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood. 2009;114:3244–3254. doi: 10.1182/blood-2009-04-217620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Deaton AM, Cook PC, De Sousa D, Phythian-Adams AT, Bird A, MacDonald AS. A unique DNA methylation signature defines a population of IFN-gamma/IL-4 double-positive T cells during helminth infection. European journal of immunology. 2014;44:1835–1841. doi: 10.1002/eji.201344098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tough DF, Tak PP, Tarakhovsky A, Prinjha RK. Epigenetic drug discovery: breaking through the immune barrier. Nat Rev Drug Discov. 2016;15:835–853. doi: 10.1038/nrd.2016.185. [DOI] [PubMed] [Google Scholar]
- 10.Tumes DJ, Onodera A, Suzuki A, Shinoda K, Endo Y, Iwamura C, Hosokawa H, Koseki H, Tokoyoda K, Suzuki Y, Motohashi S, Nakayama T. The polycomb protein Ezh2 regulates differentiation and plasticity of CD4(+) T helper type 1 and type 2 cells. Immunity. 2013;39:819–832. doi: 10.1016/j.immuni.2013.09.012. [DOI] [PubMed] [Google Scholar]
- 11.Babu S, Nutman TB. Helminth-Tuberculosis Co-infection: An Immunologic Perspective. Trends Immunol. 2016;37:597–607. doi: 10.1016/j.it.2016.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Chatterjee S, Nutman TB. Helminth-induced immune regulation: implications for immune responses to tuberculosis. PLoS pathogens. 2015;11:e1004582. doi: 10.1371/journal.ppat.1004582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, Jacobson J. Helminth infections: the great neglected tropical diseases. The Journal of clinical investigation. 2008;118:1311–1321. doi: 10.1172/JCI34261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hotez PJ, Alvarado M, Basanez MG, Bolliger I, Bourne R, Boussinesq M, Brooker SJ, Brown AS, Buckle G, Budke CM, Carabin H, Coffeng LE, Fevre EM, Furst T, Halasa YA, Jasrasaria R, Johns NE, Keiser J, King CH, Lozano R, Murdoch ME, O'Hanlon S, Pion SD, Pullan RL, Ramaiah KD, Roberts T, Shepard DS, Smith JL, Stolk WA, Undurraga EA, Utzinger J, Wang M, Murray CJ, Naghavi M. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS neglected tropical diseases. 2014;8:e2865. doi: 10.1371/journal.pntd.0002865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.McSorley HJ, Hewitson JP, Maizels RM. Immunomodulation by helminth parasites: defining mechanisms and mediators. International journal for parasitology. 2013;43:301–310. doi: 10.1016/j.ijpara.2012.11.011. [DOI] [PubMed] [Google Scholar]
- 16.Allen JE, Wynn TA. Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS pathogens. 2011;7:e1002003. doi: 10.1371/journal.ppat.1002003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Babu S, Bhat SQ, Kumar NP, Jayantasri S, Rukmani S, Kumaran P, Gopi PG, Kolappan C, Kumaraswami V, Nutman TB. Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1. The Journal of infectious diseases. 2009;200:288–298. doi: 10.1086/599797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Scott-Browne JP, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot JD, Rudensky AY, Bevan MJ, Urdahl KB. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. The Journal of experimental medicine. 2007;204:2159–2169. doi: 10.1084/jem.20062105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Mutapi F, Winborn G, Midzi N, Taylor M, Mduluza T, Maizels RM. Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-gamma, IL-4, IL-5 and IL-10 with age. BMC infectious diseases. 2007;7:139. doi: 10.1186/1471-2334-7-139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Grainger JR, Smith KA, Hewitson JP, McSorley HJ, Harcus Y, Filbey KJ, Finney CA, Greenwood EJ, Knox DP, Wilson MS, Belkaid Y, Rudensky AY, Maizels RM. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-beta pathway. The Journal of experimental medicine. 2010;207:2331–2341. doi: 10.1084/jem.20101074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Malhotra I, Mungai P, Wamachi A, Kioko J, Ouma JH, Kazura JW, King CL. Helminth- and Bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. Journal of immunology. 1999;162:6843–6848. [PubMed] [Google Scholar]
- 22.Elias D, Wolday D, Akuffo H, Petros B, Bronner U, Britton S. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination. Clin Exp Immunol. 2001;123:219–225. doi: 10.1046/j.1365-2249.2001.01446.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Reynolds LA, Redpath SA, Yurist-Doutsch S, Gill N, Brown EM, van der Heijden J, Brosschot TP, Han J, Marshall NC, Woodward SE, Valdez Y, Borchers CH, Perona-Wright G, Finlay BB. Enteric Helminths Promote Salmonella Coinfection by Altering the Intestinal Metabolome. The Journal of infectious diseases. 2017;215:1245–1254. doi: 10.1093/infdis/jix141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Cooper PJ, Chico M, Sandoval C, Espinel I, Guevara A, Levine MM, Griffin GE, Nutman TB. Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infection and immunity. 2001;69:1574–1580. doi: 10.1128/IAI.69.3.1574-1580.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Sabin EA, Araujo MI, Carvalho EM, Pearce EJ. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. The Journal of infectious diseases. 1996;173:269–272. doi: 10.1093/infdis/173.1.269. [DOI] [PubMed] [Google Scholar]
- 26.Elias D, Mengistu G, Akuffo H, Britton S. Are intestinal helminths risk factors for developing active tuberculosis? Tropical medicine & international health: TM & IH. 2006;11:551–558. doi: 10.1111/j.1365-3156.2006.01578.x. [DOI] [PubMed] [Google Scholar]
- 27.Tristao-Sa R, Ribeiro-Rodrigues R, Johnson LT, Pereira FE, Dietze R. Intestinal nematodes and pulmonary tuberculosis. Revista da Sociedade Brasileira de Medicina Tropical. 2002;35:533–535. doi: 10.1590/s0037-86822002000500020. [DOI] [PubMed] [Google Scholar]
- 28.Brown M, Miiro G, Nkurunziza P, Watera C, Quigley MA, Dunne DW, Whitworth JA, Elliott AM. Schistosoma mansoni, nematode infections, and progression to active tuberculosis among HIV-1-infected Ugandans. The American journal of tropical medicine and hygiene. 2006;74:819–825. [PubMed] [Google Scholar]
- 29.Pawlowski A, Jansson M, Skold M, Rottenberg ME, Kallenius G. Tuberculosis and HIV co-infection. PLoS pathogens. 2012;8:e1002464. doi: 10.1371/journal.ppat.1002464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin Immunol. 2014;26:454–470. doi: 10.1016/j.smim.2014.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Muraille E, Leo O, Moser M. TH1/TH2 paradigm extended: macrophage polarization as an unappreciated pathogen-driven escape mechanism? Frontiers in immunology. 2014;5:603. doi: 10.3389/fimmu.2014.00603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.DiNardo AR, Mace EM, Lesteberg K, Cirillo JD, Mandalakas AM, Graviss EA, Orange JS, Makedonas G. Schistosome Soluble Egg Antigen Decreases Mycobacterium tuberculosis-Specific CD4+ T-Cell Effector Function With Concomitant Arrest of Macrophage Phago-Lysosome Maturation. The Journal of infectious diseases. 2016;214:479–488. doi: 10.1093/infdis/jiw156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Potian JA, Rafi W, Bhatt K, McBride A, Gause WC, Salgame P. Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway. The Journal of experimental medicine. 2011;208:1863–1874. doi: 10.1084/jem.20091473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.O'Leary S, O'Sullivan MP, Keane J. IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages. American journal of respiratory cell and molecular biology. 2011;45:172–180. doi: 10.1165/rcmb.2010-0319OC. [DOI] [PubMed] [Google Scholar]
- 35.Sosroseno W, Barid I, Herminajeng E, Susilowati H. Nitric oxide production by a murine macrophage cell line (RAW264.7) stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol. 2002;17:72–78. doi: 10.1046/j.0902-0055.2001.00091.x. [DOI] [PubMed] [Google Scholar]
- 36.Mikovits JA, Young HA, Vertino P, Issa JP, Pitha PM, Turcoski-Corrales S, Taub DD, Petrow CL, Baylin SB, Ruscetti FW. Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production. Mol Cell Biol. 1998;18:5166–5177. doi: 10.1128/mcb.18.9.5166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Nakayama-Hosoya K, Ishida T, Youngblood B, Nakamura H, Hosoya N, Koga M, Koibuchi T, Iwamoto A, Kawana-Tachikawa A. Epigenetic repression of interleukin 2 expression in senescent CD4+ T cells during chronic HIV type 1 infection. The Journal of infectious diseases. 2015;211:28–39. doi: 10.1093/infdis/jiu376. [DOI] [PubMed] [Google Scholar]
- 38.Youngblood B, Noto A, Porichis F, Akondy RS, Ndhlovu ZM, Austin JW, Bordi R, Procopio FA, Miura T, Allen TM, Sidney J, Sette A, Walker BD, Ahmed R, Boss JM, Sekaly RP, Kaufmann DE. Cutting edge: Prolonged exposure to HIV reinforces a poised epigenetic program for PD-1 expression in virus-specific CD8 T cells. Journal of immunology. 2013;191:540–544. doi: 10.4049/jimmunol.1203161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Youngblood B, Reich NO. The early expressed HIV-1 genes regulate DNMT1 expression. Epigenetics. 2008;3:149–156. doi: 10.4161/epi.3.3.6372. [DOI] [PubMed] [Google Scholar]
- 40.Robert McMaster W, Morrison CJ, Kobor MS. Epigenetics: A New Model for Intracellular Parasite-Host Cell Regulation. Trends Parasitol. 2016;32:515–521. doi: 10.1016/j.pt.2016.04.002. [DOI] [PubMed] [Google Scholar]
- 41.Cizmeci D, Dempster EL, Champion OL, Wagley S, Akman OE, Prior JL, Soyer OS, Mill J, Titball RW. Mapping epigenetic changes to the host cell genome induced by Burkholderia pseudomallei reveals pathogen-specific and pathogen-generic signatures of infection. Sci Rep. 2016;6:30861. doi: 10.1038/srep30861. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Marr AK, MacIsaac JL, Jiang R, Airo AM, Kobor MS, McMaster WR. Leishmania donovani infection causes distinct epigenetic DNA methylation changes in host macrophages. PLoS pathogens. 2014;10:e1004419. doi: 10.1371/journal.ppat.1004419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Sharma G, Sowpati DT, Singh P, Khan MZ, Ganji R, Upadhyay S, Banerjee S, Nandicoori VK, Khosla S. Genome-wide non-CpG methylation of the host genome during M. tuberculosis infection. Sci Rep. 2016;6:25006. doi: 10.1038/srep25006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Sharma G, Upadhyay S, Srilalitha M, Nandicoori VK, Khosla S. The interaction of mycobacterial protein Rv2966c with host chromatin is mediated through non-CpG methylation and histone H3/H4 binding. Nucleic Acids Res. 2015;43:3922–3937. doi: 10.1093/nar/gkv261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Chandran A, Antony C, Jose L, Mundayoor S, Natarajan K, Kumar RA. Mycobacterium tuberculosis Infection Induces HDAC1-Mediated Suppression of IL-12B Gene Expression in Macrophages. Frontiers in cellular and infection microbiology. 2015;5:90. doi: 10.3389/fcimb.2015.00090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Pennini ME, Pai RK, Schultz DC, Boom WH, Harding CV. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling. Journal of immunology. 2006;176:4323–4330. doi: 10.4049/jimmunol.176.7.4323. [DOI] [PubMed] [Google Scholar]
- 47.Coussens AK, Wilkinson RJ, Martineau AR. Phenylbutyrate Is Bacteriostatic against Mycobacterium tuberculosis and Regulates the Macrophage Response to Infection, Synergistically with 25-Hydroxy-Vitamin D3. PLoS pathogens. 2015;11:e1005007. doi: 10.1371/journal.ppat.1005007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Yaseen I, Kaur P, Nandicoori VK, Khosla S. Mycobacteria modulate host epigenetic machinery by Rv1988 methylation of a non-tail arginine of histone H3. Nat Commun. 2015;6:8922. doi: 10.1038/ncomms9922. [DOI] [PubMed] [Google Scholar]
- 49.Yildirim-Buharalioglu G, Bond M, Sala-Newby GB, Hindmarch CC, Newby AC. Regulation of Epigenetic Modifiers, Including KDM6B, by Interferon-gamma and Interleukin-4 in Human Macrophages. Frontiers in immunology. 2017;8:92. doi: 10.3389/fimmu.2017.00092. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Kittan NA, Allen RM, Dhaliwal A, Cavassani KA, Schaller M, Gallagher KA, Carson WFt, Mukherjee S, Grembecka J, Cierpicki T, Jarai G, Westwick J, Kunkel SL, Hogaboam CM. Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes. PloS one. 2013;8:e78045. doi: 10.1371/journal.pone.0078045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Mandalakas AM, Kirchner HL, Lombard C, Walzl G, Grewal HM, Gie RP, Hesseling AC. Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2012;16:1033–1039. doi: 10.5588/ijtld.12.0027. [DOI] [PubMed] [Google Scholar]
- 52.Vercruysse J, Behnke JM, Albonico M, Ame SM, Angebault C, Bethony JM, Engels D, Guillard B, Nguyen TV, Kang G, Kattula D, Kotze AC, McCarthy JS, Mekonnen Z, Montresor A, Periago MV, Sumo L, Tchuente LA, Dang TC, Zeynudin A, Levecke B. Assessment of the anthelmintic efficacy of albendazole in school children in seven countries where soil-transmitted helminths are endemic. PLoS neglected tropical diseases. 2011;5:e948. doi: 10.1371/journal.pntd.0000948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Mejia R, Vicuna Y, Broncano N, Sandoval C, Vaca M, Chico M, Cooper PJ, Nutman TB. A novel, multi-parallel, real-time polymerase chain reaction approach for eight gastrointestinal parasites provides improved diagnostic capabilities to resource-limited at-risk populations. The American journal of tropical medicine and hygiene. 2013;88:1041–1047. doi: 10.4269/ajtmh.12-0726. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Lindqvist BM, Wingren S, Motlagh PB, Nilsson TK. Whole genome DNA methylation signature of HER2-positive breast cancer. Epigenetics. 2014;9:1149–1162. doi: 10.4161/epi.29632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, Irizarry RA. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30:1363–1369. doi: 10.1093/bioinformatics/btu049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27:1739–1740. doi: 10.1093/bioinformatics/btr260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Waddell SJ, Popper SJ, Rubins KH, Griffiths MJ, Brown PO, Levin M, Relman DA. Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PloS one. 2010;5:e9753. doi: 10.1371/journal.pone.0009753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Everts B, Perona-Wright G, Smits HH, Hokke CH, van der Ham AJ, Fitzsimmons CM, Doenhoff MJ, van der Bosch J, Mohrs K, Haas H, Mohrs M, Yazdanbakhsh M, Schramm G. Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses. The Journal of experimental medicine. 2009;206:1673–1680. doi: 10.1084/jem.20082460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Gause WC, Wynn TA, Allen JE. Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nature reviews Immunology. 2013;13:607–614. doi: 10.1038/nri3476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Hirahara K, Vahedi G, Ghoreschi K, Yang XP, Nakayamada S, Kanno Y, O'Shea JJ, Laurence A. Helper T-cell differentiation and plasticity: insights from epigenetics. Immunology. 2011;134:235–245. doi: 10.1111/j.1365-2567.2011.03483.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Borkow G, Bentwich Z. Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev. 2004;17:1012–1030. doi: 10.1128/CMR.17.4.1012-1030.2004. table of contents. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.van Soelen N, Mandalakas AM, Kirchner HL, Walzl G, Grewal HM, Jacobsen M, Hesseling AC. Effect of Ascaris Lumbricoides specific IgE on tuberculin skin test responses in children in a high-burden setting: a cross-sectional community-based study. BMC infectious diseases. 2012;12:211. doi: 10.1186/1471-2334-12-211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Messi M, Giacchetto I, Nagata K, Lanzavecchia A, Natoli G, Sallusto F. Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nature immunology. 2003;4:78–86. doi: 10.1038/ni872. [DOI] [PubMed] [Google Scholar]
- 64.Wen H, Dou Y, Hogaboam CM, Kunkel SL. Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response. Blood. 2008;111:1797–1804. doi: 10.1182/blood-2007-08-106443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.King CH. It's time to dispel the myth of “asymptomatic” schistosomiasis. PLoS neglected tropical diseases. 2015;9:e0003504. doi: 10.1371/journal.pntd.0003504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Kjetland EF, Leutscher PD, Ndhlovu PD. A review of female genital schistosomiasis. Trends Parasitol. 2012;28:58–65. doi: 10.1016/j.pt.2011.10.008. [DOI] [PubMed] [Google Scholar]
- 67.Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, Miyake T, Matsushita K, Okazaki T, Saitoh T, Honma K, Matsuyama T, Yui K, Tsujimura T, Standley DM, Nakanishi K, Nakai K, Akira S. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nature immunology. 2010;11:936–944. doi: 10.1038/ni.1920. [DOI] [PubMed] [Google Scholar]
- 68.Deaton AM, Webb S, Kerr AR, Illingworth RS, Guy J, Andrews R, Bird A. Cell type-specific DNA methylation at intragenic CpG islands in the immune system. Genome Res. 2011;21:1074–1086. doi: 10.1101/gr.118703.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Cook PC, Owen H, Deaton AM, Borger JG, Brown SL, Clouaire T, Jones GR, Jones LH, Lundie RJ, Marley AK, Morrison VL, Phythian-Adams AT, Wachter E, Webb LM, Sutherland TE, Thomas GD, Grainger JR, Selfridge J, McKenzie AN, Allen JE, Fagerholm SC, Maizels RM, Ivens AC, Bird A, MacDonald AS. A dominant role for the methyl-CpG-binding protein Mbd2 in controlling Th2 induction by dendritic cells. Nat Commun. 2015;6:6920. doi: 10.1038/ncomms7920. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Durzynska J, Lesniewicz K, Poreba E. Human papillomaviruses in epigenetic regulations. Mutat Res Rev Mutat Res. 2017;772:36–50. doi: 10.1016/j.mrrev.2016.09.006. [DOI] [PubMed] [Google Scholar]
- 71.Maizels RM, McSorley HJ. Regulation of the host immune system by helminth parasites. The Journal of allergy and clinical immunology. 2016;138:666–675. doi: 10.1016/j.jaci.2016.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Glass JL, Hassane D, Wouters BJ, Kunimoto H, Avellino R, Garrett-Bakelman FE, Guryanova OA, Bowman R, Redlich S, Intlekofer AM, Meydan C, Qin T, Fall M, Alonso A, Guzman ML, Valk PJM, Thompson CB, Levine R, Elemento O, Delwel R, Melnick A, Figueroa ME. Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers. Cancer Discov. 2017;7:868–883. doi: 10.1158/2159-8290.CD-16-1032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Arts RJW, Carvalho A, La Rocca C, Palma C, Rodrigues F, Silvestre R, Kleinnijenhuis J, Lachmandas E, Goncalves LG, Belinha A, Cunha C, Oosting M, Joosten LAB, Matarese G, van Crevel R, Netea MG. Immunometabolic Pathways in BCG-Induced Trained Immunity. Cell Rep. 2016;17:2562–2571. doi: 10.1016/j.celrep.2016.11.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Phan AT, Goldrath AW, Glass CK. Metabolic and Epigenetic Coordination of T Cell and Macrophage Immunity. Immunity. 2017;46:714–729. doi: 10.1016/j.immuni.2017.04.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Ghoneim HE, Fan Y, Moustaki A, Abdelsamed HA, Dash P, Dogra P, Carter R, Awad W, Neale G, Thomas PG, Youngblood B. De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation. Cell. 2017;170:142–157 e119. doi: 10.1016/j.cell.2017.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Pauken KE, Sammons MA, Odorizzi PM, Manne S, Godec J, Khan O, Drake AM, Chen Z, Sen DR, Kurachi M, Barnitz RA, Bartman C, Bengsch B, Huang AC, Schenkel JM, Vahedi G, Haining WN, Berger SL, Wherry EJ. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science. 2016;354:1160–1165. doi: 10.1126/science.aaf2807. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.